Meeting
2023 ASCO Annual Meeting
Prognostic factors in hormone receptor positive oligometastatic breast cancer.
Authors
Lacaze Jean Louis
Institut Claudius Regaud (ICR), Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Département d’Oncologie médicale, Toulouse, France
Lacaze Jean Louis , Bastien Cabarrou , Gauthier Glemarec , Clémence Brac de la Perrière , Thibaut Cassou Mounat , Ciprian Chira , Eleonora De Maio , Eva Jouve , Carole Massabeau , Vincent Nicolai , Mony Ung , Florence Dalenc
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Hormone Receptor-Positive
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1058)
DOI
10.1200/JCO.2023.41.16_suppl.1058
Abstract #
1058
Poster Bd #
279
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Lymph node metastasis to predict overall survival in oligometastatic prostate cancer in Asian patients.
First Author: Junryo Rii
Poster
2020 Gastrointestinal Cancers Symposium
The clinical prognostic significance of lymphovascular invasion in gastric cancer.
First Author: Hirohito Fujikawa
Poster
2019 Gastrointestinal Cancers Symposium
Sidedness in metastatic colorectal carcinoma: Which are the factors which influence the prognosis?
First Author: Maria Kogay
Poster
2017 ASCO Annual Meeting
Evolution of overall survival according to year of diagnosis (2008-2014) and subtypes, among 16703 metastatic breast cancer (MBC) patients included in the real-life "ESME" cohort.
First Author: Suzette Delaloge